What Cliantha Research does

Cliantha Research is a privately held, India-headquartered full-service Contract Research Organization (CRO) operating since approximately 2005 across clinical research, bioanalytical laboratory services, and biometric solutions. The company serves pharmaceutical, biotechnology, and consumer health companies, delivering projects from early-phase bioavailability/bioequivalence (BA-BE) and Phase I studies through late-phase patient-based clinical trials, alongside specialized consumer-product testing. Its therapeutic expertise spans Oncology, Dermatology, Respiratory, Vaccines, and Biosimilars.

The company's underlying technology stack combines physical infrastructure — state-of-the-art clinical sites and laboratories in India (Ahmedabad, Vadodara, Noida) and North America (St. Petersburg, Mississauga, Scarborough) — with specialized equipment including Environmental Exposure Chambers for allergy testing, Walk-In Humidity Chambers for anti-perspirant testing, and Hill Top Chambers for occlusive dermal delivery studies. Bioanalytical capabilities cover small molecule, large molecule (biologics/biosimilars), IVRT/IVPT, veterinary therapeutics, and clinical reference lab work. Biometric Solutions integrate biostatistics, programming, and data management, supported by an in-house eClinical platform for electronic trial management. Cumulative execution metrics include 8,500+ Early Phase studies, 275+ Late Phase trials, 5,500+ Consumer Clinical Research studies, 950+ validated bioanalytical methods, and 210+ successful global regulatory inspections.

Cliantha generates revenue through fee-for-service professional services contracts with enterprise clients, distributed via direct enterprise sales engagement ('Request a Proposal' channels) rather than self-service or transactional channels. The company has 1,500+ professionals and operates under founder/management ownership with no disclosed institutional investors or funding rounds. Recent visible strategic activity includes the 2014 acquisition of Karmic Lifesciences and a November 2025 Phase 2 trial completion in Toronto for Sen-Jam Pharmaceutical's SJP-001, positioning Cliantha within a multi-CRO sponsor ecosystem alongside TASK Clinical and KVK Tech. Leadership is led by CEO Vijay Patel, President Naveen Sharma, and Director Mukesh Raojibhai Patel.

Name

Cliantha Research

Legal name

Cliantha Research

Website

https://cliantha.in

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Cliantha Research is a privately held India-headquartered full-service Contract Research Organization delivering early- and late-phase clinical trials, bioanalytical lab services, and biometric solutions to pharmaceutical, biotech, and consumer health companies across India, the USA, and Canada.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Medical Laboratories (621511), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research services
• Contract research organization
• Bioequivalence studies
• Bioanalytical laboratory
• Clinical trial management

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Research Services: Contract research organization providing fee-for-service clinical research across all phases from early phase BA-BE/Phase I through late phase patient-based trials. Revenue is generated through project-based contracts with pharmaceutical, biotech, and consumer health companies.
2. Laboratory Services: Bioanalytical testing services for small molecules, large molecules, IVRT/IVPT, and clinical reference lab services billed per assay or study.
3. Consumer Clinical Research: Specialized clinical testing for consumer products including allergy testing, anti-perspirant testing, and other consumer health product studies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) providing integrated clinical research services across all phases of drug development. Its core offerings span early-phase BA-BE and Phase I studies, late-phase patient-based clinical trials, bioanalytical laboratory services for small and large molecules, and biometric/data management solutions, supported by specialized dermatology and inhalation infrastructure.

Product overview

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) offering integrated clinical research services across all phases of drug development. The company operates a unified platform combining clinical trial services (Early Phase BA-BE/Phase I, Late Phase patient-based trials, Consumer Clinical Research), comprehensive bioanalytical lab services (Small Molecule, Large Molecule, IVRT/IVPT, Veterinary Therapeutics, Clinical Reference Lab), and biometric solutions (Biostatistics & Programming, Data Management). The portfolio spans therapeutic expertise in Oncology, Dermatology, Respiratory, Biosimilars, and Vaccines, supported by specialized capabilities including Environmental Exposure Chambers for allergy testing, Walk-In Humidity Chambers for anti-perspirant testing, and Hill Top Chambers for occlusive dermal delivery studies. The company also provides eClinical solutions for electronic trial management. Cliantha Research maintains clinical sites and laboratories in India (Ahmedabad, Vadodara, Noida) and North America (St. Petersburg USA; Mississauga, Scarborough Canada).

Differentiator

Problem solved

Functional benefit

Products and services

• Early-Phase (BA-BE / Phase I) Clinical Studies Full-service early-phase clinical research including bioequivalence (BA-BE) and Phase I studies, conducted for pharmaceutical and biotech sponsors requiring FDA-, EMA-, ANVISA-, WHO-, and DCGI-compliant execution for generic and new drug development programs.
• Late-Phase Patient-Based Clinical Trials Late-phase, patient-based clinical trial management across multiple therapeutic areas for global pharmaceutical and biotech sponsors, with operations across India, North America, and Europe.
• Bioanalytical Laboratory Services In-house bioanalytical laboratory services providing validated analytical method development and sample analysis for small molecules and large molecules (biologics/biosimilars) to support clinical and bioequivalence programs for pharmaceutical and biotech sponsors.
• Biometric and Data Management Services Biometrics, data management, and biostatistics services supporting clinical trial design, database build, statistical analysis, and regulatory submission deliverables for clinical research sponsors.
• Dermatology and Inhalation Clinical Studies Specialized clinical study services for dermatology, cosmetic/topical, and inhalation products, enabled by environmental exposure chambers, humidity-controlled chambers, and in-vitro release/permeation testing (IVRT/IVPT), targeting consumer health, personal care, and pharmaceutical sponsors.

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• TASK ClinicalcoreStrategic or Co-development Partner · 11 December 2025TASK Clinical, a global contract research organization, partnered with Sen-Jam Pharmaceutical for the Phase 3 trial of SJP-001. Cliantha Research conducted the Phase 2 trial for this therapeutic in Toronto, completed in November 2025, with data readout expected in Q1 2026. TASK Clinical is funding two-thirds of the Phase 3 trial in exchange for equity.
• KVK TechcoreStrategic or Co-development PartnerKVK Tech serves as corporate venture partner to Sen-Jam Pharmaceutical, handling formulation, CMC, and FDA submission readiness. This partnership represents a vertically integrated development ecosystem. Cliantha Research conducted Phase 2 trials as part of this ecosystem.

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Parexel International: Global CRO offering clinical trial management, bioanalytical services, and regulatory consulting. Comparable full-service platform with stronger late-phase and global regulatory depth than Cliantha.
• Syneos Health: Global full-service biopharmaceutical solutions organization spanning clinical development and commercial services. Competes head-to-head with Cliantha for clinical trial outsourcing across all phases and therapeutic areas.
• Syngene International: Leading India-based CRO/CDMO offering discovery, development, and clinical research services with bioanalytical labs. Comparable integrated India-anchored CRO platform, listed on Indian exchanges with much larger disclosed scale.
• ICON plc: Top-tier global full-service CRO formed via the PRA Health Sciences merger, offering Phase I-IV clinical services, bioanalytical labs, and biometrics. Comparable integrated CRO model serving pharma/biotech across all phases, with much larger global footprint.
• Charles River Laboratories: Major CRO with strong bioanalytical, preclinical, and clinical services portfolios. Comparable bioanalytical lab capabilities and Early Phase (BA-BE/Phase I) focus, with greater scale and US-centric footprint.
• Labcorp / Fortrea (Covance spin-off): Fortrea (spun from Labcorp/Covance) is a global CRO providing Phase I-IV clinical services and central lab/bioanalytical capabilities. Directly comparable full-service model targeting pharma/biotech sponsors globally.

Broad incumbents

• Piramal Pharma Solutions: India-headquartered CDMO/CRO with clinical development and bioanalytical capabilities. Comparable integrated India-based platform with broader contract manufacturing scale than Cliantha.
• IQVIA: Largest global full-service CRO with end-to-end clinical, bioanalytical, and real-world evidence capabilities. Directly competes with Cliantha for multi-phase, multi-region pharma/biotech contracts, but at vastly greater scale and preferred-provider relationships.

Regional players

• Lambda Therapeutic Research: India-based CRO offering BA-BE/Phase I, Phase II-IV, bioanalytical, and clinical trial services. Comparable mid-tier Indian CRO competing for similar sponsors and geographies.
• Veeda Clinical Research: India-based full-service CRO offering BA-BE/Phase I, bioanalytical, and clinical research services. Closest like-for-like Indian mid-tier competitor to Cliantha with similar Early Phase and bioanalytical focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/clianthacro
• Facebookfacebook.com/cliantha.research
• LinkedInlinkedin.com/company/9211167

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cliantha Research